2020/08/15
首届冷冻电镜与药物发现创新峰会
1st GCDD Summit(Web)
报名截止日期：2020-08-14
Closing Date For Registration is August 14
Cryo-EM: From Academia to Industry
形式：线上
近年来，冷冻电镜技术推动了结构生物学的快速发展并加速了新药研发。水木未来作为亚洲第一家拥有300kV顶配冷冻电镜商用结构解析平台的公司，未来将于每年8月份举办系列国际会议。为了使冷冻电镜技术赋能新疗法的开发，2020年8月15日，水木未来将携手赛默飞举办首届冷冻电镜与药物发现创新峰会，会议邀约国内外领先学术科研机构、产业链上下游企业、产业园区、投资机构等专业人士，分享最新成果，探讨产业发展面临困境及未来发展动向，共同推动冷冻电镜技术的应用和发展。
In recent years, cryo-EM technology has driven structural biology development rapidly and accelerated new drug discovery. As the first company in Asia with a commercial structural analysis platform for 300kV top-mounted cryo-EM, Shuimu BioSciences Ltd. will host a series of international conferences in August once a year in the future. To bring the power of cryo-EM to new therapeutics developers, Shuimu BioSciences Ltd., is proud to announce that the 1st Global Innovation Institute of Cryo-EM for Drug Discovery (GCDD) Summit will be held on 8/15/2020 online. Shuimu BioSciences Ltd., cooperates with Thermo Fisher Scientific, inviting professionals from leading academic and research institutions, upstream and downstream enterprises, industrial parks, and investment institutions. Our guest speakers will share the latest achievements, discuss the dilemma faced by the industry and future development trends, and jointly promote the application and development of cryo-EM technology.
会议日程
Conference Agenda
嘉宾
嘉宾按演讲出场排序
Speakers(sorted by speech orders)
程亦凡
美国两院院士，美国加州大学旧金山分校教授、霍华德·修斯医学研究员。致力于冷冻电镜方法开发及应用。
Yifan Cheng, member of American Academy of Arts and Sciences，
member of National Academy of Sciences,Professor of University of California, San Francisco, and Investigator of Howard Hughes Medical Institute. Dedicated to the development and application of cryo-EM methods.
王宏伟
清华大学生命科学学院教授，院长，水木未来（北京）有限公司联合创始人。主要研究方向为冷冻电子显微学对生物大分子复合体的结构与分子机理研究。
Professor and dean of School of Life Sciences, Tsinghua University. Co-Founder of Shuimu BioSciences Ltd. Professor Wang's
Professor and dean of School of Life Sciences, Tsinghua University. Co-Founder of Shuimu BioSciences Ltd. Professor Wang's
main research focus is the study of the structure and molecular mechanism of biomolecular complexes by cryo-EM.
马英利
15年以上的医药生物技术研究经验，具有深厚的结构生物学专业知识。负责安进结构生物学和中国研发平台，该平台为心脏代谢疾病、肿瘤和炎症疾病领域提供小分子和生物制剂。
Yingli Ma,Executive Director, research at Amgen 15+ years, pharma-biotech-research experience with deep structural biology expertise.Responsible for Amgen structural biology and China research platforms with delivery of small molecule and biologics for
Yingli Ma,Executive Director, research at Amgen 15+ years, pharma-biotech-research experience with deep structural biology expertise.Responsible for Amgen structural biology and China research platforms with delivery of small molecule and biologics for
Cardiometabolic Diseases, Oncology and Inflammation.
Marc Peeters
Marc Peeters是赛默飞世尔科技的高级商务总监，负责亚太地区电子显微镜业务。1983年获得地质学硕士学位后一直从事电子显微镜领域工作，曾在根特大学、飞利浦电子光学公司、FEI公司任职。Marc Peeters曾担任过产品技术支持和开发应用的科学家以及各种商务管理职位。
Marc Peeters is a Sr director of sales and service at ThermoFisher scientific, responsible for the Science Electron Microscopy business in Asia Pacific. Marc has a Masters degree in Geology and has been working in the field of Electron Microscopy since 1983, at University of Ghent, Philips Electron Optics, FEI Company and now in Thermo Fisher Scientific.Marc had functions from application scientist over product support and development to various commercial and management positions.
单倍
百放英库医药科技（北京）有限公司的创始人兼首席执行官。有着二十多年新药研发经验，之前在Tularik，安进和礼来负责心血管疾病及代谢病的新药研发。于2019年5月创立百放新药孵化加速器，为教授科学家们提供全新的原创新药开发机制，致力于把突破性的科学发现转化为造福患者的原创新药。
Bei Shan, founder and CEO of BioFront Innovation Accelerator,20+ years of R&D experience in biotech and pharma R&D (Tularik, Amgen, Lilly). BioFront is a next-generation incubator/accelerator providing a one-stop solution to enable professors to translate breakthrough science to first-in-class medicines.
于江涛
高榕资本医疗健康投资顾问，水木未来（北京）有限公司董事。投资领域：具有巨大未被满足需求的新药研发和具有颠覆性的生物技术。
Dr. Jiangtao Yu, Advisor, Healthcare Sector of Gaorong Capital, Director of the Board of Shuimu BioSciences, Ltd. Investment areas: first-in-class drug discovery with huge unmet needs and disruptive biotechnology.
郭春龙
水木未来（北京）科技有限公司联合创始人兼首席执行官，连续创业者，20年的跨领域投资和企业管理经验。
Chunlong Guo, Co-founder and CEO of Shuimu BioSciences Ltd.,serial entrepreneur, with 20 years of multi-field investment and management experience.
饶燏
清华大学药学院教授, 2010年1月加入清华大学医学院。饶教授的研究兴趣主要集中在开发基于小分子的新型抗药性癌症和传染病治疗药物。近年来致力于蛋白质降解技术（PROTAC）的开发及其在相关疾病治疗中的应用。
Yu Rao,Professor, School of Pharmaceutical Sciences, Tsinghua University, joined Tsinghua University School of Medicine in January 2010. Research interests focus on developing novel small molecule based therapeutics for drug-resistant cancer and infectious disease treatments. In recent years, Professor Rao’s laboratory is mainly working on protein degradation/PROTAC method development and application in related disease treatments.
金雷
无锡佰翱得生物科学有限公司，董事兼首席运营官。剑桥大学博士，哈佛大学博士后。致力于冷冻电镜技术在基于结构的新药研发中的商业化应用。
Lei (Larry) Jin, Wuxi Biortus Biosciences Ltd., Board member and Chief Operating Officer, PhD from Cambridge University and Postdoc at Harvard.Dedicated to commercial application of cryo-EM in structure-based drug discovery.
Kenneth Borrelli
美国纽约薛定谔公司的资深科学家。Borrelli博士在薛定谔带领的研发小组正在拓展基于结构的药物发现。致力于冷冻电镜的模型改进、同源建模和ADMET建模。
Dr. Ken Borrelli is a Senior Principal Scientist at Schrodinger, Inc in New York, USA. Dr. Borrelli manages a research and development group at Schrodinger tasked with pushing the boundaries of structure-based drug discovery. His research interests include cryo-EM model refinement, homology modeling and ADMET modeling.
Pu Qian
赛默飞世尔科技冷冻电镜应用高级工程师。主要研究方向为光合作用相关膜蛋白的结构测定。在谢菲尔德大学任副研究员期间，利用二维晶体和单颗粒冷冻电镜分析确定了一系列光合细菌和植物的膜蛋白结构。
Pu Qian, Senior cryo-EM Application Engineer at Thermo Fisher Scientific.The main research interests are structural determination of photosynthesis-related membrane proteins. While staying in Sheffield University as a research associate, he determined a series of membrane protein structures from photosynthetic bacteria and plants using 2D crystal and single particle analysis of cryo-EM.
Masamichi Ashihara
赛默飞世尔科技高级产品专家。职业生涯始于赛默飞世尔科技应用专家，之后经历了产品营销工程师、销售客户经理等多种角色，最近他作为高级产品专家负责亚太区医药销售和业务发展。
Masamichi Ashihara, Sr. Product Specialist at Thermo Fisher Scientific. Career began as Application Specialist at Thermo Fisher Scientific and then experienced various roles such as Product Marketing Engineer, Sales Account Manager and most recently he is in charge of APAC Pharma Sales & Business Development as Sr. Product Specialist.
主办单位
协办单位
指导单位
媒体合作单位
会议预热
主办方视频